Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 488

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 488
---
000,000 to an existing stockholder. Warrant Exercise Notes On February 12, 2025, four holders (the “Makers”) of common stock purchase warrants (the “Warrants”) of TuHURA made and issued to TuHURA secured promissory notes (the “Warrant Exercise Notes”) in the aggregate principal amount of $3,011,373 as payment of the exercise price of an aggregate of 1,034,836 Warrants held by the Makers. The Makers were comprised of KP Biotech Group, LLC, CA Patel F&F Investments, LLC, Dr. Kiran C. Patel and Donald Wojnowski. Upon the exercise of the Warrants, TuHURA issued to the Makers an aggregate of 1,034,836 Warrant Shares, all of which are “restricted securities” within the meaning of the federal securities laws. The Warrant Exercise Notes are due and payable on May 30, 2025. Cash Flows The following table sets forth a summary of the net cash flow activity for the years ended December 31, 2024 and 2023, respectively:

|                                 |     | Year Ended December 31, 
 2024                    |             |   |     | 2023 |             |   |
|:--------------------------------|:----|:------------------------|------------:|:--|:----|:-----|------------:|:--|
| Net cash provided by (used in): |     |                         |             |   |     |      |             |   |
| Operating activities            |     | $                       | (14,728,138 | ) |     | $    | (11,950,856 | ) |
| Investing activities            |     |                         |  (6,052,409 | ) |     |      |  (1,296,879 | ) |
| Financing activities            |     |                         |  29,772,693 |   |     |      |   2,660,249 |   |
| Net increase (decrease) in cash |     | $                       |   8,992,146 |   |     | $    | (10,587,486 | ) |

Operating Activities For the year ended December 31, 2024, net cash used in operating activities was $14.7 million, which primarily consisted of a net loss of $21.7 million, a change in net operating assets and liabilities of $3.3